|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net income | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Stock-based compensation | |||
| Depreciation and amortization | |||
| Assets write-down | |||
| Inventory write-off and obsolescence | |||
| Net provision for credit losses | |||
| Gain on sale of business | |||
| Changes in value of life insurance policies | |||
| Deferred income taxes | |||
| Gain on insurance recovery on property, plant and equipment | |||
| Insurance recovery on property, plant and equipment | |||
| Realization of pension obligation | |||
| Other non-cash items | |||
| Changes in assets and liabilities: | |||
| Accounts receivable | |||
| Inventories | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable | |||
| Accrued expenses | |||
| Unearned revenues | |||
| Other liabilities | |||
| Net cash provided by operating activities | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Capital expenditures - operations | |||
| Capital expenditures - rebuilding of Aberdeen facility | |||
| Proceeds from insurance recovery - Aberdeen facility | |||
| Proceeds from sale of assets | |||
| Proceeds from sale of business, net of cash sold | |||
| Patents and other intangibles | |||
| Acquisitions, net of cash acquired | |||
| Net proceeds on life insurance policies | |||
| Net cash used in investing activities | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Repayment of long-term debt | |||
| Proceeds from long-term debt | |||
| Debt issuance costs | |||
| Proceeds from issuance of common shares | |||
| Equity related transaction costs | |||
| Dividends paid | |||
| Repurchase of common stock | |||
| Other financing activities | |||
| Net cash used in financing activities | |||
| NET CHANGE IN CASH AND CASH EQUIVALENTS | |||
| CASH AND CASH EQUIVALENTS, beginning of year | |||
| CASH AND CASH EQUIVALENTS, end of year | |||
| Supplemental disclosures of cash flow information: | |||
| Cash payments for interest | |||
| Cash payments for income taxes | |||
| Non-cash investing and financing activities: | |||
| Restricted shares withheld from employees for settlement of tax liabilities | |||
| Business acquisition contingent cash consideration | |||
| Capital expenditures incurred but not paid for as of the end of the year | |||
| Equity related transaction costs incurred but not paid for as of the end of the year |
Loading...